000 01567 a2200457 4500
005 20250514184516.0
264 0 _c20041116
008 200411s 0 0 eng d
022 _a1524-4628
024 7 _a10.1161/01.STR.0000127786.16612.A4
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWoo, Daniel
245 0 0 _aHypercholesterolemia, HMG-CoA reductase inhibitors, and risk of intracerebral hemorrhage: a case-control study.
_h[electronic resource]
260 _bStroke
_cJun 2004
300 _a1360-4 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAged
650 0 4 _aApolipoproteins E
_xgenetics
650 0 4 _aCase-Control Studies
650 0 4 _aCerebral Hemorrhage
_xchemically induced
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aHydroxymethylglutaryl-CoA Reductase Inhibitors
_xadverse effects
650 0 4 _aHypercholesterolemia
_xcomplications
650 0 4 _aMale
650 0 4 _aRisk Factors
650 0 4 _aStroke
_xcomplications
700 1 _aKissela, Brett M
700 1 _aKhoury, Jane C
700 1 _aSauerbeck, Laura R
700 1 _aHaverbusch, Mary A
700 1 _aSzaflarski, Jerzy P
700 1 _aGebel, James M
700 1 _aPancioli, Arthur M
700 1 _aJauch, Edward C
700 1 _aSchneider, Alexander
700 1 _aKleindorfer, Dawn
700 1 _aBroderick, Joseph P
773 0 _tStroke
_gvol. 35
_gno. 6
_gp. 1360-4
856 4 0 _uhttps://doi.org/10.1161/01.STR.0000127786.16612.A4
_zAvailable from publisher's website
999 _c14800858
_d14800858